Estadisticas : Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial Montemurro, F.
Visitas:866
433
204
159
25
10
6
6
6
3
3
3
2
2
2
2
Descargas: 422